The 2024 updated Basel Statements on the future of hospital pharmacy
August 14, 2026
In this podcast, Stephen Eckel and Michael Stepanovic discuss the AJHP Descriptive Report "The 2024 updated Basel Statements on the future of hospital pharmacy” with host and AJHP Editor in Chief Daniel Cobaugh.
SPEAKERS
Stephen F. Eckel, PharmD, MHA is the associate dean for global engagement at the UNC Eshelman School of Pharmacy and an associate professor in the Division of Practice Advancement and Clinical Education. In addition, he is director of the two-year Master of Science in pharmaceutical sciences with a specialization in health-system pharmacy administration. At UNC Medical Center, he is residency program director of the 2-year program in health-system pharmacy administration.
Michael Stepanovic, PharmD, MS is an assistant professor at the UNC Eshelman School of Pharmacy, specializing in health-system pharmacy administration and leadership. He is actively engaged with the International Pharmaceutical Federation (FIP) and the American Society of Health-System Pharmacists (ASHP), contributing to global pharmacy practice advancement and policy initiatives. His work focuses on leadership development, supply chain strategy, and innovation, with an emphasis on translating global standards into practice and advancing the future of hospital pharmacy.
Daniel J. Cobaugh, PharmD, FAACT, DABAT is the senior vice president of professional development and publishing at ASHP and the editor-in-chief of AJHP. He has served on the ASHP staff since 2002. He received his B.S. in Pharmacy from the University of Pittsburgh and his Doctor of Pharmacy from Duquesne University. Cobaugh completed an ASHP-accredited residency in hospital pharmacy at Mercy Hospital of Pittsburgh and a clinical toxicology fellowship at the Pittsburgh Poison Center. He practiced as pharmacist-clinical toxicologist and held faculty appointments at the University of Pittsburgh Medical Center and the University of Rochester Medical Center.
LISTEN ON
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ADVERTISEMENT